Annals of Family Medicine
NOVEMBER 20, 2024
This project is based on a grant given to provide infant mortality health education and promotion interventions to low-income families at Hawthorne Landing, an apartment complex in Fairborn. Context Fairborn is a city in Greene County, Ohio.
Physician's Weekly
JUNE 19, 2025
Reform: Needed & Possible The authors noted that while bias against mental health and SUD histories still shapes some emergency encounters, targeted education, objective protocols, and integrated behavioral services can narrow the gap between expected and delivered care, improving outcomes for a vulnerable, high‑utilization population.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Clinical Problem Solvers
SEPTEMBER 28, 2019
Dr.’s Vivek Murthy, Bridget O’Brien, and Gurpreet Dhaliwal sought to answer this question in a 2018 study. It could argued that today’s learners are entering the medical field at a time of unprecedented educational resources, and the implications for the development of clinical reasoning skills is awe-inspiring.
The Medical Futurist
JUNE 21, 2025
Their research showed promising results for lab rats, and they plan to carry out the first human trials in the second half of 2017 and gather preliminary results during 2018. Harbisson received a specialised electronic eye, his “eyeborg” to be able to render perceived colours as sounds on the musical scale. and a specificity of 95.5%.
FDA Law Blog
JULY 7, 2021
In March 2020, FDA issued a final rule that banned the use of Graduated Electronic Decelerators (GEDs) to treat patients with severe self-injurious and aggressive behaviors (SIB/AB), but did not restrict the use of these same devices for other purposes, like smoking cessation. FDA cleared 510(k)s for GEDs in the 1990s.
FDA Law Blog
JULY 10, 2023
Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 During the recent Regulatory Education for Industry (REdI) Annual Conference, June 6-10, 2022 , FDA presented “Tips from a Lead Reviewer” for the presentation titled “Detangling the 510(k) Process.”
GeriPal
SEPTEMBER 7, 2023
William: So ASCO decided to make a high priority this year to redo the guidelines, which were originally released in 2018. So I would say that a lot of the education we received were on cutting edge research and the latest drugs in clinical trials, the latest cellular therapies that are coming out. This is terrific. John: Right.
Expert insights. Personalized for you.
130 
Let's personalize your content